APOC3 and metabolic dysfunction-associated steatotic liver disease: By mitigating oxidative stress and restoring redox homeostasis, aucubin significantly alleviated liver injury associated with NAFLD in a tyloxapol-induced mouse model of non-alcoholic fatty liver disease (NAFLD) and apoC-III-stimulated 3T3-L1 cells.